Overexpression or dysregulation of LSD1 has been observed in various cancers, including gastric cancer, small cell lung cancer (SCLC), breast cancer [18,19], neuroblastoma [20], acute myeloid leukemia (AML), retinoblastoma [21], and prostate cancer [22,23,24]. Here, KDM1A is linked to acute myeloid leukemia.